OCULAR THERAPEUTIX, INC Payments to Acquire Investments
OCULAR THERAPEUTIX, INC (OCUL) reported Payments to Acquire Investments of $75.01 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2015-11-10
- OCULAR THERAPEUTIX, INC payments to acquire investments for the quarter ending 2015-09-30 was $57.51M.
- OCULAR THERAPEUTIX, INC payments to acquire investments for the quarter ending 2015-06-30 was $0.00.
- OCULAR THERAPEUTIX, INC payments to acquire investments for the quarter ending 2015-03-31 was $17.50M.
- OCULAR THERAPEUTIX, INC payments to acquire investments for fiscal 2014 was $37.33M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2015-09-30 | $57.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $57.51M derived: sum of 2 quarters · filed 2015-11-10 | $75.01M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $17.50M 10-Q · filed 2015-08-10 | ||
| 2015-03-31 | $17.50M 10-Q · filed 2015-05-15 | |||
| 2014-12-31 | $37.33M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |